Compound C108 - ≥98% , CAS No.15533-09-2

CAS: 15533-09-2 Cat. No.: C649291 Fórmula: C15H14N2O3 Peso molecular: 270.28 Número EC: 111-040-4 PubChem CID: 135472588
Disponible para pedir
CALIDAD & PUREZA ≥98%
Storage
Protected from light,Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Talla
USA
Alemania (EU)*
Precio
Cantidad
5mg
C649291-5mg
Fabricado bajo pedido · 8–12 semanas

146,90US$

220,90US$
Guardar 74,00 US$ (33.50%)
10mg
C649291-10mg
Fabricado bajo pedido · 8–12 semanas

263,90US$

395,90US$
Guardar 132,00 US$ (33.34%)
25mg
C649291-25mg
Fabricado bajo pedido · 8–12 semanas

575,90US$

863,90US$
Guardar 288,00 US$ (33.34%)
50mg
C649291-50mg
Fabricado bajo pedido · 8–12 semanas

978,90US$

1.468,90US$
Guardar 490,00 US$ (33.36%)
100mg
C649291-100mg
Fabricado bajo pedido · 8–12 semanas

1.663,90US$

2.495,90US$
Guardar 832,00 US$ (33.33%)
Enter a quantity for the sizes you want to add.

Descripción general

Compound C108 is a G3BP2 inhibitor. Compound C108 also targeted stress granule-associated proteins and Gtpase-activating protein (SH3 domain) binding protein 2. Compound C108 potently inhibits esophageal squamous cell carcinoma (ESCC) cell metastasis

In Vitro

Compound C108 (1 μM; 24 h) shows anti-tumor activity against BT474 cells. Compound C108 (4 μM; 24 h) significantly decreases the protein expression of G3BP2 in G3BP2 overexpressing KYSE410 cells and LINC01554 transfected KYSE30 cells. Compound C108 (4 μM; 24 h) attenuates ESCC cell metastasis, migration and invasion in KYSE410, KYSE30 and KYSE150 cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: G3BP2-overexpressing KYSE410 cells, LINC01554-transfected KYSE30 cells Concentration: 4 μM Incubation Time: 24 h Result: Decreased the protein level of G3BP2 and HDGF.

In Vivo

Compound C108 (1 μM; 24 h) targets and decreases tumor initiating cells (TICs), while injected BT-474 cells treated with Compound C108 into the mammary fat pad of female nonobese diabetic/severe combined immune deficiency (NOD-SCID) mice in a limiting-dilution xenograft assay . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

IC50& Target:G3BP2

Especificaciones

Especificaciones y pureza
≥98%
Mecanismos bioquímicos y fisiológicos
Compound C108 is a G3BP2 inhibitor. Compound C108 also targeted stress granule-associated proteins and Gtpase-activating protein (SH3 domain) binding protein 2. Compound C108 potently inhibits esophageal squamous cell carcinoma (ESCC) cell metastasis
Condiciones de almacenamiento de almacenamiento
Protected from light,Store at -80°C
Enviado en
Dry ice packs + Cold packs
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Tipo de acción
INHIBITOR
Pureza
≥98%
Nombres e identificadores
Sonrisas canónicas
CC(=NNC(=O)C1=CC=CC=C1O)C2=CC=CC=C2O
IUPAC Name
2-hydroxy-N-[(E)-1-(2-hydroxyphenyl)ethylideneamino]benzamide
InChIKey
LQGMBUGEAAGJKW-MHWRWJLKSA-N
INCHI
1S/C15H14N2O3/c1-10(11-6-2-4-8-13(11)18)16-17-15(20)12-7-3-5-9-14(12)19/h2-9,18-19H,1H3,(H,17,20)/b16-10+
PubChem CID
135472588
Peso molecular
270.28

Datos avanzados

Estructura 3D
Modelo de Estructura Química Interactiva





Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propiedades químicas y físicas
SolubilidadDMSO : 25 mg/mL (92.50 mM; Need ultrasonic)
Peso molecular270.280 g/mol
XLogP32.900
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass270.1 Da
Monoisotopic Mass270.1 Da
Topological Polar Surface Area81.900 Ų
Heavy Atom Count20
Formal Charge0
Complexity370.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds1
Covalently-Bonded Unit Count1
Calculadoras de soluciones
Reseñas

Reseñas de cliente

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.